Patients with obstructive sleep apnea are at great risk of flavor disorders: a 15-year population-based cohort study

Huang, Hsin-Hsin; Wu, Min-You; Hung, Yao-Min; Tsao, Chien‐Han; Wei, James Cheng‐Chung; Wen, Wei-Sheng; Wang, Yu‐Hsun; Hung, Shih-Yen; Chao, Max Min

doi:10.1007/s00784-022-04707-3

Cited by 7 publications

(6 citation statements)

References 60 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Likewise, as underlying inflammatory processes may trigger or exacerbate fibromyalgia and its comorbidities, 13 educational modules that cover anti-inflammatory lifestyle and medications may largely benefit patients with fibromyalgia or chronic widespread pain who have concomitant inflammatory rheumatic diseases, including rheumatic arthritis or ankylosing spondylitis. 14 These lifestyle determinants include diet, smoking, drinking, sleep, [15][16][17][18] and other habits that serve as risk factors for fibromyalgia, 19 for which lifestyle modifications may promote symptom alleviation and improve the quality of life of patients with fibromyalgia.…”

mentioning

confidence: 99%

Pain neuroscience education for fibromyalgia

Chan

Lin

et al. 2023

Int J of Rheum Dis

View full text Add to dashboard Cite

mentioning

confidence: 99%

Pain neuroscience education for fibromyalgia

Chan

Lin

et al. 2023

Int J of Rheum Dis

View full text Add to dashboard Cite

“…Patients with and without OSA were separated in the study by Thakur et al, using diagnostic criteria including the International Classification of Diseases, 9th Revision, Clinical Modification (ICD‐9‐CM), the Berlin questionnaire, and apnea‐hypopnea index (AHI) 1 . However, as the severity of OSA could be stratified by AHI, 2 subgroup analyses based on AHI could be employed to reflect the association between the severity of OSA and the incidence of RA. Aside from AHI, respiratory disturbance index (RDI) 3 and whether sleep surgeries 4,5 including tonsillectomy or adenoidectomy, uvulopalatopharyngoplasty, hyoid suspension, genioglossus advancement, or maxillomandibular advancement were performed may also indicate the severity of OSA.…”

Section: Contentsmentioning

confidence: 99%

Obstructive sleep apnea in patients with rheumatoid arthritis: The multidisciplinary approach and multidimensional assessment

et al. 2022

View full text Add to dashboard Cite

“…1,2 Obstructive sleep apnea (OSA) is a syndrome characterized by the recurrent anatomical narrowing and collapsing of the upper airway during one's sleep period, resulting in intermittent arterial desaturation and hypoxemia, sleep arousals, and sympathetic hyperactivity. 3,4 Obstructive sleep apnea is determined by the number of times apnea and hypopnea occur per hour during the sleep period based upon the apnea-hypopnea index (AHI). It can be measured through a polysomnography (PSG) and reflects the true physiology of breathing during sleep.…”

Section: Introductionmentioning

confidence: 99%

The prevalence of obstructive sleep apnea syndrome after COVID‐19 infection

Lin,

Wu,

Wang

et al. 2024

Journal of Medical Virology

View full text Add to dashboard Cite

Obstructive sleep apnea is a well‐known risk factor regarding the severity of COVID‐19 infection. However, to date, relatively little research performed on the prevalence of obstructive sleep apnea in COVID‐19 survivors. The purpose of this study was to investigate the risk of obstructive sleep apnea after COVID‐19 infection. This study was based on data collected from the US Collaborative Network in TriNetX. From January 1, 2020 to June 30, 2022, participants who underwent the SARS‐CoV‐2 test were included in the study. Based on their positive or negative results of the COVID‐19 test results (the polymerase chain reaction [PCR] test), we divided the study population into two groups. The duration of follow‐up began when the PCR test was administered and continued for 12 months. Hazard ratios (HRs) and 95% confidence intervals (CIs) for newly recorded COVID‐19 positive subjects for obstructive sleep apnea were calculated using the Cox proportional hazards model and compared to those without COVID‐19 infection. Subgroup analyses were performed for the age, sex, and race, groups. The COVID‐19 group was associated with an increased risk of obstructive sleep apnea, at both 3 months of follow‐up (HR: 1.51, 95% CI: 1.48–1.54), and 1 year of follow‐up (HR: 1.57, 95% CI: 1.55–1.60). Kaplan–Meier curves regarding the risk of obstructive sleep apnea revealed a significant difference of probability between the two cohorts in the follow‐up periods of 3 months and 1 year (Log‐Rank test, p < 0.001). The risks of obstructive sleep apnea among COVID‐19 patients were significant in the less than 65 year of age group (HR: 1.50, 95% CI: 1.47–1.52), as well as in the group older than or equal to 65 years (HR:1.69, 95% CI: 1.64–1.73). Furthermore, the risks of obstructive sleep apnea were evident in both the male and female COVID‐19 groups. Compared to the control group, the risks of obstructive sleep apnea in the COVID‐19 participants increased in the subgroups of White (HR: 1.62, 95% CI: 1.59–1.64), Blacks/African Americans (HR: 1.50, 95% CI: 1.45–1.55), Asian (HR: 1.46, 95% CI: 1.32–1.62) and American Indian/Alaska Native (HR: 1.36, 95% CI: 1.07–1.74). In conclusion, the incidence of new diagnosis obstructive sleep apnea could be substantially higher after COVID‐19 infection than non‐COVID‐19 comparison group. Physicians should evaluate obstructive sleep apnea in patients after COVID‐19 infection to help prevent future long‐term adverse effects from occurring in the future, including cardiovascular and neurovascular disease.

show abstract

Patients with obstructive sleep apnea are at great risk of flavor disorders: a 15-year population-based cohort study

Cited by 7 publications

References 60 publications

Pain neuroscience education for fibromyalgia

Pain neuroscience education for fibromyalgia

Obstructive sleep apnea in patients with rheumatoid arthritis: The multidisciplinary approach and multidimensional assessment

The prevalence of obstructive sleep apnea syndrome after COVID‐19 infection

Contact Info

Product

Resources

About